Member Info for BOJO2020

Needs to find the bottom IMO.

It may drop much further than current levels of 21.5p IMO.

The next phase of the haverion project will be drawn out and will no doubt pay out big time (50p plus? Maybe a £1??) Timing is key with GGP. Not time to buy and if you do, be prepared to wait.

Anything under 1p is good for UFO. Managed to get in at .33 myself last year so have a decent holding. It is all about the volume...!

C7,

I agree with Ruck. The company were wise to issue the RNS. I think they were just covering the base in case people complained it was an unfounded rise. Clearly it has been a long time coming.

Especially pleased at your own good news and that Scancell were able to put in a great performance for you and LTH to boot!

WTP,

BBC News Channel about 8.40 or 8.45pm.

The piece was concerning south Asian and black communities not taking up the vaccines. Although it was a piece from BBC East Midlands that the main news decided to show.

Not sure if they will show it in an hour again (SKY usually do this).

It was really odd how they linked vaccine take up to our vaccine or ‘Nottingham Vaccine’. The only link of course was the fact that both fall within East Midlands.

Hope that helps.

Sorry that is Janet Daley

Just been on main BBC News. However they framed it as Nottingham University and not Scancell. Typical BBC no conviction just in case someone complains they have a view!

Scientist Janet Daly commenting if that rings a bell??

WTP,

Yes I am very happy with the finish and managed increase holding at no cost.

Good Luck LTH!!

Welcome new members. Please take time to get to know Scancell thoroughly. Well worth it IMO.

Mornington,

Never thought I would say this to you of all people but do your research!!

£8 will not be hit anytime soon IMO but it can be achieved. Scancell is not just about COVIDITY.

I believe the SP may swing in both directions but the value of the vaccines/therapeutics here should not be under estimated.

I get what people are saying £8 is very rampy and is not likely based on phase 1 of the COVIDITY trial but there are many ways in which value can be added to the business. Just look at the portfolio. I do believe such high valuations will take many years.

ATB

John,

Pay further attention to the Sclp SP.

Plenty of trading there imo. Doubles difficult from current levels but should swing 5 or 6p IMO. I fully expect it to pass 30p but swiping profits is hard as LTH trade it to accumulate more shares.

I don’t the k you have any worries with COPL but a double is not a given IMO.

Managed to accumulate 15k for free today but in my SIPP.

Waiting in ECR and OMI. If I have further funds I will add GGP if price is 20p level.

Good Luck.

Ihowells & Nolupus,

You certainly pick some interesting stocks. Once other stocks deliver for me I will take a good luck at your tips.

ATB.

Are you holding or trading a few OMI John?

No trouble buying or selling Sclp on interactive investors.

Fidelity NT as usual!!

Knowlesi,

You play a valuable role on this BB. No problem with alternative views. It is up to each of us to have conviction in our beliefs and to listen to others (occasionally).

Knowlesi,

Is it possible you are trying to buy more shares on the cheap? If so why do that on positive news flow? (Rhetorical)

You are clearly a Scancell fan. I sense the passion and belief you have so why deny it!

ATB

COVIDITY - Phase 1 trials start early summer 2021. Not only that but they are developing a separate vaccine now that may deal with SA and Brazil variant. In any case I do believe SP will increase with news flow. For example this weekends Telegragh, Times, The Sun, Nee York Post articles. Not to mention being Sky Tv all day today at approx 10 to the hour every hour!

SCIB1 - CRUK who had agreed to pay for the trial have just pulled out half way through. As a charity they have had to re evaluate trials they are backing. Understandable as cancer trials have largely been cancelled across the world.

MODI 1 - Collaboration with BionTech on going.

Also have employed chief scientific officer and operating officer in Nov 2020 with a view to making trials for 4 products happen this year.

Red mile have bought up to the limit of nearly 30%. Any more they would have had to make an offer which was clearly not their intention.

Cash in bank £58 million.

This does not count £20 million awarded by Innovate Uk to develop COVIDITY.

13.5 to 14p sounds like a bargain!!!

There will be many bumps in the road as Scancell shed the dead wood (therapies that are proven not to work) but there is a reason why Lindy Durrant has close intellectual links with BionTech IMO. They need her as much as she needs them. More compelling is that they are both involved with Redmile.

Redmile don’t back losers as far as I can tell.

These are facts that are easily available from many sources.

ATB

Nolupus,

Scancell will need a partner to hit 2022 deadline.

IMO I am looking at phase 1 trial in early summer. It could reach 35 to 40p by then. On the other hand it may hit that tomorrow...

My approach is one hurdle at a time. Phase 1 is just an opportunity to make money although I did not buy in for COVIDITY (COVID vaccine).

I bought in initially as I could see the LTH stuck with Sclp when it failed years ago.it is very very sticky stock. Then Redmile piled in so I topped up and followed the money :-).

Next 5 years I believe it could be worth a ridiculous sum per share. It only needs one of its novel therapeutics to work or be bought.

Chief Scientist Lindy Durrant is one of the outstanding in her field of immunology. No one disputes that.

COVIDITY has provided a shortcut to success IMO.

Redmile Investments fully loaded!!

Vulpes Investments fully loaded!!

BOJO2020 fully loaded!!

HM Goverment (innovate Uk) on board!!

Don’t leave it to long or you will have to pay a premium!

Look at the cash position. The SP is unlikely to drop below 14p IMO DYOR.

Morning 1509,

Can’t really sum up Scancell in a sentence. They are not gimmicky. They have not been looking to solve COVID, but they may have the ability to do so. The science is much deeper than that. It just so happens that the areas of therapeutics/immunology/vaccines and delivery apply to this particular Corona Virus.

The approach is not dissimilar to BionTech and in fact they have collaborated when both were up and coming with similar unique approach to science. That was whilst Redmile were turning BionTech into the giant it is now. In fact Redmile have now moved onto Scancell and invested heavily. It is my opinion that Scancell are the bride in waiting and will be the next big thing and their Covidity vaccine is just a platform to show the much wider scientific capabilities.

I would suggest that for those that enjoy deep research into a company and the science it would be very interesting. Even if you don’t invest you will learn something.

Or for those that simply want to double or treble from current SP (13.5p) it is very possible over the next weeks/months. We have just been waiting for a catalyst and the recent press coverage may well be it.

ATB and do you own research.

P.S Scancell bb members will answer sensible questions. (Not how much is this going to be worth next week!!!)

Excuse spellings as I am using my phone.

P.S.S Look into treatments. Delivery systems. Future immunity etc. Scancell are researching the lot! Big ambitions....!!!!

This board is good for tips.

Take a read of this article in the New York Post. Also use links to articles in The Telegraph and The Sun.

https://nypost.com/2021/02/13/uk-company-developing-vaccine-to-fight-covid-19-variants/

I think one way or another this could be a big earner... Even if the vaccine does not make it in the end. UK government are on board to some degree by allocating £20 million...

ATB

Fekir,

For what it’s worth I believe you holding BMN and SNG will see you right. I admire your conviction.

SNG are up against approved therapeutics so they are rightly not getting the exposure that holders of that stock expect!

That said, if you are still holding then I would think you are holding stock with great potential. Who knows!

As I have mentioned before holding a stock through phase 3 trials is a risky long journey but maybe life changing in every sense of the term.

ATB